Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02262741
Brief Title: A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 (Durvalumab) With Tremelimumab in Head and Neck Cancer

First Submitted : October 2, 2014
First Submitted that Met QC Criteria : October 9, 2014
First Posted : October 13, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : October 20, 2017
Last Update Posted : October 23, 2017